The U.S. Food and Drug Administration inspected Baylor University Medical Center Transfusion Services in Dallas on April 22 for blood and blood products, based on data available on the FDA’s website.
The inspection concluded that Baylor University Medical Center Transfusion Services was not required to address or correct any portion of the organization’s operations.
The FDA conducts regular inspections of facilities nationwide to check compliance with laws and regulations that support public health. Results of these inspections are made available to the public.
The agency’s website notes that the FDA is responsible for overseeing the safety and quality of human and animal drugs, biological products, medical devices, and tobacco items.
Information for this article comes from the U.S. Food and Drug Administration. The original data is accessible here.
